April 26, 2024 News by Marisa Wexler, MS Machine learning model predicts CIS to MS conversion risk: Study A new machine learning model is able to predict the risk of converting from clinically isolated syndrome, or a first event of multiple sclerosis (MS)-like symptoms, to clinically definite disease, a study found. “Our study developed a machine-learning model that not only provides a numerical estimate of the…
April 25, 2024 Columns by Benjamin Hofmeister Finding safety while living with the constant threat of MS progression Even as a small child, I enjoyed watching nature shows. They didn’t come on television often, but when they did, I absorbed every word. At school, I might not have been able to recite the Pythagorean theorem, but I could say with confidence that butterflies taste with their feet. That…
April 25, 2024 News by Margarida Maia, PhD Having MS may marginally increase likelihood of cervical cancer: Study There’s no evidence to suggest that multiple sclerosis (MS) directly causes most cancers, but having the condition may marginally increase the likelihood of developing cervical cancer, according to a new study from China. That study found “no causal relationship between MS and 15 types of cancers except cervical cancer,”…
April 25, 2024 News by Marisa Wexler, MS MS patients prefer Tysabri injection to intravenous infusion: Study People with multiple sclerosis (MS) who are being treated with Tysabri (natalizumab) tend to prefer receiving the medication as a subcutaneous (under-the-skin) injection rather than an intravenous (into-the-vein) infusion, according to new data from an observational study. “Based on current data, there is a trend toward patients’ preference…